Page 1

NovoSorbⓇ BTM PolyNovo PolyNovo Limited ABN 96 083 866 862 2/320 Lorimer Street Port Melbourne VIC Australia 3207 P +61 ( 0 ) 3 8681 4050 F +61 ( 0 ) 3 8681 4099 20 October 2021 ASX Announcement COVID Trading Themes UK , Ireland and EU open for business The EU is open for business and appears to be living with Covid . Face to face meetings are back , conferences are being attended and hospital access has returned to near normal levels . We expect to sign additional distributors in Q2 , including Cyprus and the Czech Republic . Other jurisdictions such as France and Portugal are in negotiation . The EU performed well up 204 % in Q1 FY22 over Q1 FY21 . A new 3PL distribution centre in Belgium is operational and filling sales orders with deliveries to Germany , Finland , and an order from Italy being filled this week . All indications are that orders will commence soon to other distributors in Poland , Turkey , and Greece . The relaxation of Covid restrictions in UK and Irish hospitals has been positive for the business , also buoyed by some clinical trials . Q1 FY22 sales were up 327 % on same quarter last year . Patchy trading in the US Notwithstanding the continued limited access to US hospitals and surgeons , a record new accounts were opened in Q1 FY22 and total accounts in the US are up 65 % on Q1 FY21 . Our recently expanded sales team ( now 36 ) is trained and making inroads into new territories . Q1 FY22 started strongly with total sales for July and August up 56 % on last year . September '21 sales included mixed results resulting in Q1 FY22 sales being up 21 % . NZ / Australia a tale of two cities Australia and New Zealand results were impacted by the extended hard lockdowns in NSW and Victoria . We expect sales to improve with the easing of Covid restrictions in Q2 . New accounts in our direct markets ( excluding distributor markets ) in Q1 FY22 were up 56 % on Q1 FY21 . Improving outcomes . Changing lives .